LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Aug 2, 2019
Product Development
Boehringer plays catch-up in NASH, dives into new modalities across the board
Keeping to early stage deals, Boehringer places smaller bets on big risks
Read More
BioCentury
|
Jul 2, 2019
Company News
Boehringer races to catch up in NASH through Yuhan deal
Read More
BioCentury
|
Nov 2, 2018
Financial News
NASH company Terns raises $80M series B
Read More
BioCentury
|
Nov 1, 2018
Finance
OrbiMed’s NASH Terns
Why OrbiMed led $80 million B round for U.S.-China NASH company Terns
Read More
BioCentury
|
Oct 30, 2018
Financial News
NASH company Terns raises $80M series B
Read More
BioCentury
|
Apr 6, 2018
Company News
Terns acquires NASH compounds from Eli Lilly
Read More
BioCentury
|
Apr 4, 2018
Company News
Terns acquires NASH compounds from Eli Lilly
Read More
BioCentury
|
Feb 16, 2009
Finance
Ebb & Flow
Read More
BioCentury
|
Feb 13, 2009
Clinical News
La Jolla falls after stopping Riquent trial
Read More
BioCentury
|
Dec 19, 2005
Clinical News
La Jolla Pharma preclinical data
Read More
Items per page:
10
1 - 10 of 12
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help